1,000
Participants
Start Date
January 1, 2021
Primary Completion Date
November 30, 2029
Study Completion Date
November 30, 2030
Deep brain stimulation
The surgical intervention named deep brain stimulation is a well-established neurosurgical treatment for moderate-to-advanced stage PD. The targets used in this study are STN and GPi, which are widely accepted and used for symptom control in PD. The devices used for intervention have been approved by Chinese National Medical Products Administration (CFDA). The postoperative drug dosage adjustment depends on the efficacy of DBS and the judgment of the movement disorder specialist.
Huashan Hospital
OTHER
Shanghai Tongji Hospital, Tongji University School of Medicine
OTHER
The First Affiliated Hospital with Nanjing Medical University
OTHER
First Affiliated Hospital, Sun Yat-Sen University
OTHER
The First Affiliated Hospital of Guangzhou Medical University
OTHER
West China Hospital
OTHER
Second Affiliated Hospital of Soochow University
OTHER
Tianjin Huanhu Hospital
OTHER
Guangzhou General Hospital of Guangzhou Military Command
OTHER
The Affiliated Hospital of Xuzhou Medical University
OTHER
Ruijin Hospital
OTHER